Global H1N1 Vaccines Market

Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global H1N1 vaccines market reached a value of US$ 3.4 billion in 2021. Looking forward, the market is projected to reach US$ 4.6 billion by 2027, exhibiting at a CAGR of 5.4 % during 2022-2027. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

The H1N1 virus is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.

Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the H1N1 flu infection.

However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.

Key Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global H1N1 vaccines market, along with forecasts at the global and regional level from 2022-2027. The report has categorized the market based on vaccine type, key brands and market type.

• Breakup by Vaccine Type

• Intramuscular

• Intranasal

• Intradermal

Breakup by Market Type:

• Public

• Private

Analysis of Key Brands:

• Agripal

• Fiuarix

• Influgen

• Influvac

• Nasovac

• Vaxigrip

• Others

Breakup by Region:

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• Latin America

Competitive Landscape

The report has also examined the competitive landscape of the market and provides the profiles of the key players operating in the industry.

This report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines industry in any manner.

Key Questions Answered in This Report

• How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?

• What are the key regional markets?

• What has been the impact of COVID-19 on the global H1N1 vaccines industry?

• What are the popular vaccines type?

• What are the major market types?

• What are the various stages in the value chain of the global H1N1 vaccines industry?

• What are the key driving factors and challenges in the global H1N1 vaccines market?

• What is the structure of the global H1N1 vaccines industry and who are the key players?

• What is the degree of competition in the industry?

• What are the profit margins in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global H1N1 Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Breakup by Vaccines Type
5.5 Breakup by Market Type
5.6 Analysis of Key Brands
5.7 Breakup by Region
5.8 Market Forecast

6 Market Breakup by Vaccines Type
6.1 Intramuscular
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intranasal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intradermal
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Type
7.1 Public
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast

9 Analysis of Key Brand
9.1 Agripal
9.2 Fiuarix
9.3 Influgen
9.4 Influvac
9.5 Nasovac
9.6 Vaxigrip
9.7 Others

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis

14 Industry Developments
14.1 Pipeline and New Product Launches
14.2 Mergers & Acquisitions and Partnerships

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/njc74r

Attachment

• Global H1N1 Vaccines Market

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900